Telix Pharmaceuticals Ltd reports

Company location: North Melbourne, Australia
Fiscal year end: 31 December

Telix Pharmaceuticals Ltd has filed 97 SEC EDGAR filings since 25 Jan 2024

Filter by type:
20-F
6-K

SEC filing history

Showing 51-55 of 55 matching filings.

Per page

25

Current page

3

6-K File 001-42128

CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS

Filing date: 13 Jan 2025
Reporting date: 13 Jan 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-42128

CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS

Filing date: 13 Jan 2025
Reporting date: 12 Jan 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-42128

CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS

Filing date: 30 Dec 2024
Reporting date: 29 Dec 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-42128

6-K

Filing date: 19 Nov 2024
Reporting date: 19 Nov 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-42128

6-K

Filing date: 14 Nov 2024
Reporting date: 12 Nov 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .